General Information of Drug (ID: DMDEI9X)

Drug Name
ISIS 104254 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMDEI9X

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-CRP DMQDUG4 Cardiovascular disease BA00-BE2Z Phase 1 [2]
NM-PP1 DMS8H5Q Discovery agent N.A. Investigative [2]
ISIS 104258 DMUC3L0 Discovery agent N.A. Investigative [1]
ISIS 104211 DMPKQ61 Discovery agent N.A. Investigative [1]
ISIS 104257 DMSDCGV Discovery agent N.A. Investigative [1]
ISIS 104256 DMHUX9A Discovery agent N.A. Investigative [1]
ISIS 104255 DMAI5B8 Discovery agent N.A. Investigative [1]
ISIS 104253 DMME8JP Discovery agent N.A. Investigative [1]
Src kinase inhibitor I DMUZP9V Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
RIP2 messenger RNA (RIP2 mRNA) TTCQ2E5 RIPK2_HUMAN Not Available [1]

References

1 US patent application no. 6,426,221, Antisense modulation of RIP2 expression.
2 The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297-315.